Theranostic treatment for prostate cancer involves targeting prostate specific membrane antigen (PSMA) on prostate cancer cells – first with a radioactive molecule to reveal the cancer’s spread via a PET scan and then a similar radioactive molecule that kills cancer cells. The ProsTIC program has t...See more
Headquarters:
Australia
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2019 (7 years)
Address:
305 GRATTAN STREET; MELBOURNE, VIC 3000, AU
Employees by Department
Key Decision Makers
Financials
LOW
spending power
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has PROSTIC THERANOSTICS been operating for?
- What is the funding status of PROSTIC THERANOSTICS?
- Where is PROSTIC THERANOSTICS's headquarter?
- What PROSTIC THERANOSTICS's spending power?
- Does PROSTIC THERANOSTICS have a presence in the domain it operates in?
